Moderated by Marian Gindy, PhD, Executive Director, Discovery Pharmaceutical Sciences, Merck, this panel discussion recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference explores how mRNA vaccines represent a promising alternative to conventional vaccine approaches for infectious diseases as well as oncology indications, including an emerging application for personalized cancer vaccines. The panelists for the session are: Örn Almarsson, PhD, Head of Formulations, Moderna TherapeuticsDanilo Casimiro, PhD, VP and Head, External R&D and Vaccine Platforms, SanofiChristian W Mandl, PhD, MD, Chair, Scientific Advisory Board and Co-Founder, Tiba BiotechJinJun Shi, PhD, Associate Professor, Harvard Medical School and Faculty Member, Center for Nanomedicine at Brigham and Women’s HospitalSybil Williams, PhD, Senior Principal Scientist, Personalized Cancer Biology Lead, Merck Save the date for the 9th annual PODD business development event on October 7-8, 2019 at the Renaissance Boston Waterfront Hotel in Boston. PODD covers the latest advances in drug delivery science, while also providing a meeting place to network and form new partnerships. To learn more about the event, please visit PODD 2019.